Expert Systems

Expert Systems is the target of global clinical accelerators. It deploys a comprehensive hybrid platform based on AI/ML, covering all aspects of preclinical drug discovery and early development, from target identification and virtual screening to non-clinical and clinical pharmacology, including chemical liability assessment and toxicology. Expert Systems uses proprietary and public databases and software tools to evaluate the intellectual property landscape and provide competitive intelligence to reduce the risk of candidate selection, enabling a rapid transition from in silico to first-in-human. Expert Systems establishes seed round and Series A companies, organizing and managing R&D projects for financial investors and strategic partners in North America, Europe, and Australia.